OPKO HEALTH, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $606.9M | $713.1M | $863.5M | $1.0B | $1.8B |
| Cost of revenue | $400.9M | $494.6M | $545.4M | $716.0M | — |
| Gross profit | $205.9M | $218.5M | $318.1M | $288.2M | — |
| Selling, general & administrative | $223.0M | $304.2M | $300.6M | $372.7M | $468.9M |
| Research and development | $124.0M | $105.2M | $89.6M | $73.9M | $76.8M |
| Operating expenses | — | — | $1.0B | $1.2B | $1.8B |
| Operating income | -$117.4M | -$152.1M | -$157.0M | -$226.3M | $18.8M |
| Interest expense | $0 | $47.5M | $13.5M | $12.1M | $18.9M |
| Pretax income | -$241.4M | -$10.4M | -$184.3M | -$391.5M | -$14.0M |
| Income tax expense | -$15.7M | $42.8M | $4.4M | -$63.5M | $15.5M |
| Net income | -$225.7M | -$53.2M | -$188.9M | -$328.4M | -$30.1M |
| Balance Sheet | |||||
| Cash and equivalents | $364.4M | $426.6M | $95.9M | $153.2M | $134.7M |
| Current assets | $581.9M | $662.1M | $309.5M | $394.5M | $823.0M |
| Total assets | $1.9B | $2.2B | $2.0B | $2.2B | $2.4B |
| Current liabilities | $146.7M | $193.1M | $200.1M | $213.5M | $330.0M |
| Total liabilities | $664.0M | $834.8M | $622.5M | $605.6M | $714.6M |
| Stockholders' equity | $1.3B | $1.4B | $1.4B | $1.6B | $1.7B |
| Cash Flow Statement | |||||
| Cash from operations | -$178.5M | -$183.5M | -$28.2M | -$95.2M | $38.3M |
| Depreciation and amortization | $91.6M | $98.2M | $105.3M | $108.7M | $78.7M |
| Stock-based compensation | $10.7M | $11.0M | $11.4M | $18.5M | $13.6M |
| Capital expenditure | $12.3M | $25.0M | $16.3M | $24.6M | $32.2M |
| Free cash flow | -$190.8M | -$208.5M | -$44.5M | -$119.8M | $6.2M |
| Share repurchases | $47.0M | $90.2M | $0 | $0 | — |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 755.1M
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.